Information  X 
Enter a valid email address

Omega Diagnostics Gp (ODX)

  Print   

Monday 19 April, 2021

Omega Diagnostics Gp

Director/PDMR Shareholding

RNS Number : 8005V
Omega Diagnostics Group PLC
19 April 2021
 

 

19 April 2021

 

OMEGA DIAGNOSTICS GROUP PLC

 

("Omega" or the "Company" or the "Group")

 

Director/PDMR Shareholding

 

 

 

Omega Diagnostics (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance testing, announces that Derek Brady, Group Strategic Sourcing Director has sold in total 14,673 ordinary shares of 4 pence each in the capital of the Company ("Ordinary Shares"), at a price of 95 pence per share. Following the sale Mr. Brady holds no Ordinary Shares.

 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014.The below notification is made in accordance with the requirements of the EU Market Abuse Regulation.

 

Contacts: 

 

Omega Diagnostics Group PLC 

Tel: 01259 763 030

Colin King, Chief Executive 

www.omegadiagnostics.com

Kieron Harbinson, Group Finance Director

 

 

 

 

 

finnCap Ltd  

Tel: 020 7220 0500

Geoff Nash / Teddy Whiley (Corporate Finance)

 

Alice Lane (ECM)

 

 

 

Walbrook PR Limited

Tel: 020 7933 8780 or [email protected]

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

 

 

 

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

Derek Brady

2

Reason for notification

 

a.

Position/Status

PDMR (Group Strategic Sourcing Director)

b.

Initial notification/

Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Omega Diagnostics Group Plc

b.

LEI

2138007U9P4BTZTYIR92

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrument

Identification Code

 Ordinary Shares of 4 pence each

 

ISIN:  GB00B1VCP282

b.

Nature of the transaction

Sale of Ordinary Shares

c.

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

 

95p

14,673

Sale

 

d.

Aggregated information

Aggregated Purchase Volume

Aggregated Purchase Price

Aggregated Sale Volume

Aggregated Sale Price

As above. 

 

e.

Date of the transaction

13 April 2021

f.

Place of the transaction

London Stock Exchange

                 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBRGDSSXBDGBL

a d v e r t i s e m e n t